Claiming that FDA is currently hampered in evaluating “potentially false or misleading structure/function claims,” the U.S. Government Accountability Office (GAO) has recommended in a new report that the agency be given the power to request evidence of substantiation from companies.
Claiming that FDA is currently hampered in evaluating “potentially false or misleading structure/function claims,” the U.S. Government Accountability Office (GAO) has recommended in a new report that the agency be given the power to request evidence of substantiation from companies making the claims “to establish whether there is scientific support for the claims.”
The GAO report points out that while the FTC, which is responsible for protecting consumers from false advertising, can require companies to submit relevant evidence, including proprietary market and scientific research, when investigating whether claims are substantiated, FDA currently does not have that legal authority.
“GAO recommends FDA identify and request from Congress authorities to access companies’ evidence for potentially false or misleading structure/function claims on food to establish scientific support, provide guidance to industry on the evidence it needs to support such claims, and provide direction to FDA inspectors to help identify claims for further review,” the GAO report states.
The government watchdog is now awaiting FDA’s response to its recommendation.
Negative View
In general, the GAO report seems to take a negative view on qualified health claims and structure-function claims, calling them “a serous oversight dilemma” for FDA. The report states that consumers are becoming confused by the types of health claims on the market and states that more companies are now using structure-function claims in lieu of FDA-approved health claims.
“Research showed, and stakeholders indicated, that consumers find it difficult to understand the differences between health claims with significant scientific agreement and the lower level of scientific support for qualified health claims. Research also showed that consumers find it difficult to distinguish among the many different types of claims on food labels, including health claims, qualified health claims, and structure/function claims,” the report says.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”